Daniel Herz-Roiphe
Chief Operating Officer at Priovant Therapeutics
📍 United States
Professional overview including current role context, leadership scope, domain focus, and career trajectory to help you understand background relevance before outreach.
Key behavioral and communication insights including interaction style, decision-making tendencies, and motivation drivers to tailor messaging and personalize conversations.
Business priorities, areas of interest, and practical outreach recommendations that can improve conversion quality for this professional.
Experience
11 Years
Current Role
Chief Operating Officer
Job Level
Leadership
Location
United States
Personality Overview
Personality insights not availableWe need more social data to generate the DISC analysis and selling playbook. The professional details below are still available.
Priorities
Topics Daniel cares about
Strategic Priorities
Topic insights and context to help personalize outreach and discovery conversations.
Career
Work history
10-2021
Chief Operating Officer
Priovant Therapeutics
10-2019 - 10-2021
Chief Operating Officer & General Counsel
VantAI
3-2020 - 9-2021
Executive Chair, Lokavant & VantAI
Roivant Sciences
1-2019 - 3-2020
Head of Legal, Roivant Health
Roivant Sciences
11-2018 - 1-2019
Legal Counsel (secondee)
Palantir Technologies
In the press
Media appearances
Media appearances and press coverage highlighting public visibility and thought leadership.
Login to view
Education
J.D.
Yale Law School
B.A.
Harvard University
Social presence
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.